Bachem Holding AG (BCHMF)
OTCMKTS · Delayed Price · Currency is USD
61.43
-2.63 (-4.10%)
At close: May 21, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
Commercial Active Pharmaceutical Ingredients | 327.00M | Log In | Log In | Log In | Log In | Upgrade |
Commercial Active Pharmaceutical Ingredients Growth | 5.82% | Log In | Log In | Log In | Log In | Upgrade |
Clinical Medicines Category Development | 234.44M | Log In | Log In | Log In | Log In | Upgrade |
Clinical Medicines Category Development Growth | 3.04% | Log In | Log In | Log In | Log In | Upgrade |
Research & Specialties | 43.81M | Log In | Log In | Log In | Log In | Upgrade |
Research & Specialties Growth | 7.48% | Log In | Log In | Log In | Log In | Upgrade |
Research Chemicals | - | Log In | Log In | Log In | Log In | Upgrade |
Research Chemicals Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
United States | 183.80M | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 138.66M | Log In | Log In | Log In | Log In | Upgrade |
Denmark | 112.40M | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | 75.43M | Log In | Log In | Log In | Log In | Upgrade |
Ireland | 54.11M | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom | 40.86M | Log In | Log In | Log In | Log In | Upgrade |
Europe / Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Europe / Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
North America | - | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | - | Log In | Log In | Log In | Log In | Upgrade |